NeurologyLive® Brain Games: May 28, 2023

Article

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is Alzheimer disease and dementia.

Welcome to NeurologyLive® Brain Games! This weekly quiz series, which goes live every Sunday morning, will feature questions on a variety of clinical and historical neurology topics, written by physicians, clinicians, and experts in the fields of neurological care and advocacy.

Test your mettle each week with 3 questions that cover a variety of aspects in the field of neurology, with a focus on dementia and Alzheimer disease, epilepsy and seizure disorders, headache and migraine, movement disorders, multiple sclerosis, neuromuscular disorders, sleep disorders, and stroke and cerebrovascular disease.

This week's questions include the theme of Alzheimer disease and dementia.

Click here to check out the prior iterations of Brain Games.

Interested in submitting quiz questions? Contact our managing editor, Matt Hoffman, via email: mhoffman@neurologylive.com.

By 2060, the number of people with Alzheimer disease is expected to reach what number?


Alzheimer disease is one of the top 10 leading causes of death overall in the United States. Among US adults, though, it is the _____ leading cause of death.




In addition to memory problems, an individual with symptoms of Alzheimer disease may experience one or more of the following (select all that apply).


How did you do on this week's quiz? Let us know with a response to the poll below. Don't forget to share and compare your results with your friends!

How many questions did you get correct?

One
Two
Three

Related Videos
Shahid Nimjee, MD, PhD
Peter J. McAllister, MD, FAAN
Video 6 - "Utilization of Neuroimaging in Alzheimer’s Disease"
Video 5 - "Contribution of Multiple Pathways to the Development of Alzheimer’s Disease"
Michael Levy, MD, PhD
Michael Levy, MD, PhD
Michael Kaplitt, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.